Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.
İş dünyası · 31.01.19941 dk okuma
Opportunity for a License: Assay To Screen Inhibitors of HIV-1 Aspartyl Protease
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The National Institutes of Health desires to license (in accordance with 35 U.S.C. 207) a novel radiometric assay system for identifying potential new anti-retroviral drugs that target HIV-1 aspartyl proteinase. This retroviral proteinase processes viral proteins and permits their assembly into the structural components of the infectious HIV-1 virions. If this enzyme activity can be inhibited, no mature infectious viral particles are produced.
Kaynağın orijinal dili: Federal Register — Health and Human ServicesOrijinal duyuruyu açın →